2-hydroxy-5-[[(p-tolyl)sulphonyl]oxy]benzenesulphonic acid, compound with piperazine (1:1)
| 中文名称 | 2-hydroxy-5-[[(p-tolyl)sulphonyl]oxy]benzenesulphonic acid, compound with piperazine (1:1) |
|---|---|
| 中文同义词 | 化合物 T28882;SULTOSILIC ACID 哌嗪盐 |
| 英文名称 | 2-hydroxy-5-[[(p-tolyl)sulphonyl]oxy]benzenesulphonic acid, compound with piperazine (1:1) |
| 英文同义词 | Piperazine salt;2-hydroxy-5-[[(p-tolyl)sulphonyl]oxy]benzenesulphonic acid, compound with piperazine (1:1);Mimedran;piperazine-sultosylate;Sultosilic acid, piperazine salt;A-585;A 585;A585 |
| CAS号 | 57775-27-6 |
| 分子式 | C17H22N2O7S2 |
| 分子量 | 430.49578 |
| EINECS号 | 260-944-6 |
| 相关类别 | |
| Mol文件 | 57775-27-6.mol |
| 结构式 | ![2-hydroxy-5-[[(p-tolyl)sulphonyl]oxy]benzenesulphonic acid, compound with piperazine (1:1) 结构式](CAS/20180808/GIF/57775-27-6.gif) |
2-hydroxy-5-[[(p-tolyl)sulphonyl]oxy]benzenesulphonic acid, compound with piperazine (1:1) 性质
| 熔点 | 174° |
|---|---|
| 形态 | 固体 |
Sultosilic acid piperazine salt (Piperazine sultosylate; A-585) 是一种降脂药。Sultosilic acid piperazine salt 可以调节血脂水平，降低血小板粘附性，而不会促进肝细胞的过氧化物酶体活性或产生其他不良副作用。
安全信息
| 毒性 | LD50 i.p. in beagles, male rats, female rats: 605, 833.6, 1272 mg/kg; orally in rats: >11 g/kg (Rodriguez) |
|---|